Home > E. Pathology by systems > Skin > cutaneous myxoma
cutaneous myxoma
Wednesday 21 June 2017
superficial angiomyxoma
WKP | PO |
Definition: A cutaneous myxoma, a.k.a. superficial angiomyxoma, consists of a multilobulated myxoid mass containing stellate or spindled fibroblasts with pools of mucin forming cleft-like spaces. There is often a proliferation of blood vessels and an inflammatory infiltrate.
Synopsis
hypocellular tumors / hypocellularity
composed of bland cells,
no mitotic activity,
no lipoblasts,
scant blood vessels;
may have focal histiocytes
Slightly more cellular with collagenized capsule at periphery
May have areas of increased vascularity or be hypercellular (Am J Surg Pathol 1998;22:1222)
Slightly basophilic matrix with usually a few spindle cells at high power with oval nuclei
May have central mucinous cyst
At periphery, may infiltrate striated muscle and be associated with muscle atrophy
Immunochemistry
Immunostaining is :
positive for vimentin ,
negative for cytokeratin and desmin ,
variable for CD34 (50%), Factor VIIIa , SMA , MSA and S-100.
Clinically, it may present as solitary or multiple flesh-colored nodules on the face, trunk, or extremities. Local recurrence is common.
It may occur as part of the Carney complex , and is sometimes the first sign.
Differential diagnosis : cutaneous myxoid tumors
Myxoid or mucinous background change is a common finding in a wide variety of cutaneous tumors and other diseases.
Myxoid tumors often have overlapping features and may show significant heterogeneity from area to area within a given specimen and from individual case to case.
As prognosis and treatment vary considerably between many of these entities, accurate diagnosis is essential.
Myxoid tumors include :
superficial angiomyxoma (cutaneous myxoma )
superficial acral fibromyxoma (digital fibromyxoma )
dermal nerve sheath myxoma (conventional neurothekeoma )
myxoid dermatofibrosarcoma protuberans ,
giant cell fibroblastoma ,
low-grade fibromyxoid sarcoma ,
myxofibrosarcoma ,
myxoinflammatory fibroblastic sarcoma
Molecular biology
GNAS1 mutations in 61% of intramuscular myxomas (Mod Pathol 2009;22:718)
No cytogenetic aberrations
See also
angiomyxoid tumors
cutaneous tumors
myxomas